株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アトピー性皮膚炎 - 現在・将来の市場参入企業

Atopic Dermatitis - Current and Future Players

発行 GlobalData 商品コード 293251
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
アトピー性皮膚炎 - 現在・将来の市場参入企業 Atopic Dermatitis - Current and Future Players
出版日: 2015年11月03日 ページ情報: 英文 58 Pages
概要

当レポートでは、世界のアトピー性皮膚炎の関連市場における既存企業および新規参入企業について分析し、市場全体の将来展望や促進・抑制要因、現在・将来の競争動向、主要企業のプロファイル(事業内容、戦略、業績、SWOT分析)などを調査・考察しています。

第1章 目次

第2章 イントロダクション

  • 分析の背景
  • 関連調査
  • 刊行予定の関連調査

第3章 市場の見通し

  • 世界市場
    • 市場予測
    • 世界市場の促進・阻害要因

第4章 現在・将来の市場参入企業

  • 概要
  • 企業戦略の傾向
  • 企業プロファイル

第5章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1050FPR

GlobalData has released its pharma report, "Atopic Dermatitis - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Atopic Dermatitis Market. The report identifies and analyses the key companies shaping and driving the global Atopic Dermatitis market. The report provides insight into the competitive Atopic Dermatitis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Atopic Dermatitis
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Atopic Dermatitis sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Atopic Dermatitis market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Atopic Dermatitis market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Outlook

  • 3.1. Global Markets
    • 3.1.1. Forecast
    • 3.1.2. Global Drivers and Barriers

4. Current and Future Players

  • 4.1. Overview
  • 4.2. Trends in Corporate Strategy
  • 4.3. Company Profiles
    • 4.3.1. Astellas
    • 4.3.2. Meda
    • 4.3.3. Sanofi/Regeneron/Boehringer Ingelheim
    • 4.3.4. Anacor

5. Appendix

  • 5.1. Bibliography
  • 5.2. Abbreviations
  • 5.3. Methodology
  • 5.4. Forecasting Methodology
    • 5.4.1. Diagnosed Atopic Dermatitis Patients
    • 5.4.2. Percent Drug-treated Patients
    • 5.4.3. Drugs Included in Each Therapeutic Class
    • 5.4.4. Launch and Patent Expiry Dates
    • 5.4.5. General Pricing Assumptions
    • 5.4.6. Individual Drug Assumptions
    • 5.4.7. Generic Erosion
    • 5.4.8. Pricing of Pipeline Agents
  • 5.5. Physicians and Specialists Included in this Study
  • 5.6. Primary Research - Prescriber Survey
  • 5.7. About the Authors
    • 5.7.1. Author
    • 5.7.2. Reviewer
    • 5.7.3. Epidemiologist
    • 5.7.4. Global Director of Therapy Analysis and Epidemiology
    • 5.7.5. Global Head of Healthcare
  • 5.8. About GlobalData
  • 5.9. Disclaimer

List of Tables

  • Table 1: Global Sales Forecasts ($m) for Atopic Dermatitis, 2014-2024
  • Table 2: Global Atopic Dermatitis Market - Drivers and Barriers, 2014-2024
  • Table 3: Key Companies in the Atopic Dermatitis Market, 2015
  • Table 4: Astellas Pharma's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 5: Astellas Pharma SWOT Analysis, 2015
  • Table 6: Meda's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 7: Meda SWOT Analysis, 2015
  • Table 8: Regeneron's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 9: Regeneron SWOT Analysis, 2015
  • Table 10: Anacor's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 11: Anacor's SWOT Analysis, 2015
  • Table 12: Key Launch Dates
  • Table 13: Key Patent Expiries
  • Table 14: Physicians Surveyed, By Country

List of Figures

  • Figure 1: Global Sales for Atopic Dermatitis by Region, 2012-2022
  • Figure 2: Company Portfolio Gap Analysis in Atopic Dermatitis, 2014-2024
Back to Top